Core Viewpoint - The company, Furuida, is undergoing a transformation by divesting from real estate and focusing on the health and beauty sector, but it is facing challenges with declining revenues and profits in its cosmetics segment in the first three quarters of 2025 [1][24]. Financial Performance - For the first three quarters of 2025, Furuida reported a total revenue of 2.597 billion yuan, a year-on-year decrease of 7.34% [2][24]. - The net profit attributable to shareholders was 142 million yuan, down 17.19% compared to the same period last year [2][24]. - In Q3 alone, the revenue was 807 million yuan, a decline of 7.97% year-on-year, with a net profit of 34 million yuan, down 23.07% [2][24]. Cosmetics Segment Analysis - The cosmetics segment revenue for the first three quarters was approximately 1.569 billion yuan, reflecting an 8.17% decline [4][24]. - The brand performance within the cosmetics segment varied significantly, with the brand Yilian experiencing a growth rate of nearly 20%, while the brand Aier Bozhi saw a decline of 28.93% [1][12]. Brand Performance - Yilian's sales reached 786 million yuan, up 19.50%, with its spray product line generating 664 million yuan, a 28% increase [12][24]. - Aier Bozhi's sales for the first nine months were 646 million yuan, marking a decline of 28.93% [12][24]. - The newly introduced brand, Kemi, reported sales of 77.19 million yuan, with a significant quarter-on-quarter growth of 138% [15][24]. Research and Development - Furuida's R&D expenses reached 116 million yuan, an increase of 11.8%, with an R&D expense ratio of 4.46%, the highest in the past five years [19][24]. - The company is focusing on product innovation and has established a data platform for ideal skin microbiomes, along with several medical device registrations [22][24]. Strategic Focus - Following the divestment from real estate, Furuida is concentrating on health and beauty, particularly in cosmetics, biomedicine, and related products [4][24]. - The company is implementing a "5+N" brand strategy to transition from a single beauty focus to a dual beauty model encompassing both cosmetic and medical aesthetics [7][24].